FDA Inspection 1090371 — Vitalant
The FDA completed an inspection of Vitalant on May 15, 2019 in Placerville, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 15, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Placerville, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 18074 | 21 CFR 630.10(c) | Donor Eligibility on day of donation |